$19.30
0.77% yesterday
Nasdaq, Oct 15, 10:05 pm CET
ISIN
IL0011794802
Symbol
CLBT
Industry

Cellebrite DI Stock price

$19.30
+1.87 10.73% 1M
-0.04 0.21% 6M
-2.73 12.39% YTD
+1.21 6.69% 1Y
+14.90 338.64% 3Y
+9.64 99.79% 5Y
+9.64 99.79% 10Y
+9.64 99.79% 20Y
Nasdaq, Closing price Wed, Oct 15 2025
-0.15 0.77%
ISIN
IL0011794802
Symbol
CLBT
Industry

Key metrics

Basic
Market capitalization
$4.7b
Enterprise Value
$4.2b
Net debt
positive
Cash
$472.2m
Shares outstanding
244.5m
Valuation (TTM | estimate)
P/E
negative | 39.0
P/S
10.7 | 9.7
EV/Sales
9.6 | 8.7
EV/FCF
28.1
P/B
11.4
Financial Health
Equity Ratio
48.7%
Return on Equity
-84.2%
ROCE
13.0%
ROIC
679.4%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$436.7m | $479.7m
EBITDA
$72.4m | $122.4m
EBIT
$61.9m | $114.7m
Net Income
$-151.0m | $122.1m
Free Cash Flow
$149.0m
Growth (TTM | estimate)
Revenue
20.5% | 19.6%
EBITDA
19.8% | 81.3%
EBIT
23.2% | 101.5%
Net Income
-46.1% | 143.1%
Free Cash Flow
71.1%
Margin (TTM | estimate)
Gross
84.4%
EBITDA
16.6% | 25.5%
EBIT
14.2%
Net
-34.6% | 25.5%
Free Cash Flow
34.1%
More
EPS
$-0.6
FCF per Share
$0.6
Short interest
6.2%
Employees
1k
Rev per Employee
$340.0k
Show more

Is Cellebrite DI a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,003 stocks worldwide.

Cellebrite DI Stock Analysis

Unlock Scores for Free

Analyst Opinions

14 Analysts have issued a Cellebrite DI forecast:

13x Buy
93%
1x Hold
7%

Analyst Opinions

14 Analysts have issued a Cellebrite DI forecast:

Buy
93%
Hold
7%

Financial data from Cellebrite DI

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
437 437
20% 20%
100%
- Direct Costs 68 68
19% 19%
16%
369 369
21% 21%
84%
- Selling and Administrative Expenses 199 199
20% 20%
46%
- Research and Development Expense 107 107
21% 21%
25%
72 72
20% 20%
17%
- Depreciation and Amortization 11 11
3% 3%
2%
EBIT (Operating Income) EBIT 62 62
23% 23%
14%
Net Profit -151 -151
46% 46%
-35%

In millions USD.

Don't miss a Thing! We will send you all news about Cellebrite DI directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Cellebrite DI Stock News

Neutral
GlobeNewsWire
about 13 hours ago
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced its Autumn 2025 Release , evolving and advancing its Digital Investigation Platform with new integrations and powerful new capabilities that span from collection and review to advan...
Positive
Seeking Alpha
about one month ago
Upgrading Cellebrite to buy as leadership uncertainty is resolved and new CEO/CFO bring proven execution experience. Rapid adoption of Inseyets and Guardian platforms, with SaaS/cloud ARR growing >50% y/y, signals strong product-market fit and stickier customer relationships. FedRAMP High sponsorship and Corellium acquisition unlock new high-value markets and accelerate long-term growth potenti...
Neutral
Seeking Alpha
2 months ago
Cellebrite DI Ltd. (NASDAQ:CLBT ) Q2 2025 Earnings Call August 14, 2025 8:30 AM ET Company Participants Adam H.
More Cellebrite DI News

Company Profile

Cellebrite DI Ltd. engages in the provision of digital investigative solutions for the public and private sectors, empowering organizations in mastering the complexities of legally sanctioned digital investigations by streamlining intelligence processes. Its services include training and advisory, value realization, advanced services, and technical customer support. The firm also offers software solutions and analytic tools designed to accelerate digital investigations and address the growing complexity of handling crime and security challenges in the digital era. The company was founded on April 13, 1999 and is headquartered in Petach Tikva, Israel.

Head office Israel
CEO Thomas Hogan
Employees 1,167
Founded 1999
Website www.cellebrite.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today